Literature DB >> 803847

Antigenic and antiheparin properties of human platelet factor 4 (PF4).

N Nath, C T Lowery, S Niewiarowski.   

Abstract

Platelet factor 4 (PF4, a heparin-neutralizing protein) was isolated from washed human platelets. It was found to be homogenous by SDS-polyacrylamide gel electrophoresis, immunodiffusion, and immunoelectrophoresis, when tested with monospecific antibody produced in rabbits. PF4 is a heat-stable protein, but its antiheparin activity and antigenicity are destroyed by trypsin. The molecular weight of PF4 as calculated by amino acid analysis is approximately 8000 and by SDS-polyacrylamide gel electrophoresis with beta-mercaptoethanol, 7100 daltons. PF4 migrated to the cathode at pH 8.6. The interaction of PF4 with heparin resulted in the formation of a complex which migrated to the anode, as tested by immunoelectrophoresis. Incubation of purified PF4 with its antibody at 37 degrees C resulted in a loss of antiheparin activity. The presence of antiheparin activity and of PG4 antigen in material released during platelet aggregation by various agents and at various stages of the preparative procedure closely correlated. It has been concluded that PF4 antigen and antiheparin activity are two properties of the same protein. Comparison of human and pig PF4 revealed significant biochemical and antigenic differences.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 803847

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  5 in total

1.  Effect of heparin and prostacyclin-heparin infusion on blood coagulation in haemodialysed patients.

Authors:  M Kuźniewski; W Sułowicz; J Lisiewicz
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

2.  Amino acid sequence of human platelet factor 4.

Authors:  T F Deuel; P S Keim; M Farmer; R L Heinrikson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-06       Impact factor: 11.205

3.  In vitro hematological and in vivo vasoactivity assessment of dextran functionalized graphene.

Authors:  Sayan Mullick Chowdhury; Shruti Kanakia; Jimmy D Toussaint; Mary D Frame; Anthony M Dewar; Kenneth R Shroyer; William Moore; Balaji Sitharaman
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

4.  Platelet proteins, including platelet-derived growth factor, specifically depress a subset of the multiple components of the response elicited by glutathione in Hydra.

Authors:  K Hanai; H Kato; S Matsuhashi; H Morita; E W Raines; R Ross
Journal:  J Cell Biol       Date:  1987-06       Impact factor: 10.539

5.  In vivo Biocompatibility, Biodistribution and Therapeutic Efficiency of Titania Coated Upconversion Nanoparticles for Photodynamic Therapy of Solid Oral Cancers.

Authors:  Sasidharan Swarnalatha Lucky; Niagara Muhammad Idris; Kai Huang; Jaejung Kim; Zhengquan Li; Patricia Soo Ping Thong; Rong Xu; Khee Chee Soo; Yong Zhang
Journal:  Theranostics       Date:  2016-07-18       Impact factor: 11.556

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.